Guidance on the use of cyclo-oxygenase (Cox) II selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis.
National Institute for Clinical Excellence (Great Britain)
London : National Institute for Clinical Excellence,
2001.
Cover title.